Loading market data...

Mankind Pharma IPO

Branded Pharmaceuticals / FMCG Pharma - Listed on 09 May 2023

+20.4% listing gain
Issue Price (Upper)
Rs 1,080
Listing Price
Rs 1,300
Closing Price (NSE)
Rs 1,422.3
Total Subscription
15.32x

Mankind Pharma IPO listing summary

Mankind Pharma (Branded Pharmaceuticals / FMCG Pharma) closed its IPO window in 2023 and listed on NSE and BSE on 09 May 2023 at an upper band issue price of Rs 1080, opening at Rs 1300 for a listing gain of +20.4% and closing day one at Rs 1422.3 (+31.7% on closing basis). The IPO was subscribed 15.32x overall - QIB 49.16x, HNI/NII 3.80x, Retail 0.92x. The total issue size was Rs 4,326.36 Cr (Fresh Issue Rs 0 Cr, OFS Rs 4326.36 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+20.37%
Listing Gain (Close)
+31.69%
Day Change After Listing
+11.32%
Retail Quota
35.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB49.16x
HNI / NII3.80x
Retail0.92x
Overall15.32x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 10.14x
Day 20.87x
Day 3 (Final)15.32x

Mankind Pharma IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 75+6.94%
Day 2Rs 75+6.94%
Day 3Rs 85+7.87%
Day 4Rs 70+6.48%
Day 5Rs 45+4.17%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
4.2%-7.9%
IPOGyani AI Prediction
-
Actual Listing Gain
+20.4%

Issue & financials

Issue SizeRs 4,326.36 Cr
Fresh IssueRs 0 Cr
OFSRs 4,326.36 Cr
IPO PE30.18
Peer / Sector PE38.00
PE vs Sector Ratio0.79
Latest EBITDA (Cr)25.75
Debt / Equity0.08

Market context at listing

How the broader market moved around the Mankind Pharma IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return+0.06%
Nifty 1W Return+0.65%
Nifty 1M Return+3.79%
Nifty during IPO window+2.80%

Mankind Pharma IPO - FAQs

What was the listing gain of Mankind Pharma IPO?

Mankind Pharma IPO listed at +20.4% versus the upper issue price of Rs 1,080 on 09 May 2023.

How many times was Mankind Pharma IPO subscribed?

Mankind Pharma IPO was subscribed 15.32x overall. QIB portion was subscribed 49.16x, HNI / NII 3.80x and Retail 0.92x.

What was the IPO GMP for Mankind Pharma?

IPO GMP started at Rs 75 on Day 1 and moved to Rs 45 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2023

Browse listed IPOs by year